Found: 19
Select item for more details and to access through your institution.
Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 9, p. 3997, doi. 10.1172/JCI67892
- By:
- Publication type:
- Article
Dual leucine zipper kinase-dependent PERK activation contributes to neuronal degeneration following insult.
- Published in:
- eLife, 2017, p. 1, doi. 10.7554/eLife.20725.001
- By:
- Publication type:
- Article
Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour models.
- Published in:
- Journal of Pathology, 2012, v. 227, n. 4, p. 417, doi. 10.1002/path.4053
- By:
- Publication type:
- Article
EGFR Inhibitor Erlotinib Delays Disease Progression but Does Not Extend Survival in the SOD1 Mouse Model of ALS.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0062342
- By:
- Publication type:
- Article
Residual Tumor Cells That Drive Disease Relapse after Chemotherapy Do Not Have Enhanced Tumor Initiating Capacity.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0045647
- By:
- Publication type:
- Article
Active PI3K Pathway Causes an Invasive Phenotype Which Can Be Reversed or Promoted by Blocking the Pathway at Divergent Nodes.
- Published in:
- PLoS ONE, 2012, v. 7, n. 5, p. 1, doi. 10.1371/journal.pone.0036402
- By:
- Publication type:
- Article
FGF19 Regulates Cell Proliferation, Glucose and Bile Acid Metabolism via FGFR4-Dependent and Independent Pathways.
- Published in:
- PLoS ONE, 2011, v. 6, n. 3, p. 1, doi. 10.1371/journal.pone.0017868
- By:
- Publication type:
- Article
Combined Targeting of BRAF and CRAF or BRAF and PI3K Effector Pathways Is Required for Efficacy in NRAS Mutant Tumors.
- Published in:
- PLoS ONE, 2009, v. 4, n. 5, p. 1, doi. 10.1371/journal.pone.0005717
- By:
- Publication type:
- Article
In vivo quantification of murine aortic cyclic strain, motion, and curvature: Implications for abdominal aortic aneurysm growth.
- Published in:
- Journal of Magnetic Resonance Imaging, 2010, v. 32, n. 4, p. 847, doi. 10.1002/jmri.22331
- By:
- Publication type:
- Article
Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival.
- Published in:
- Nature, 2010, v. 463, n. 7277, p. 103, doi. 10.1038/nature08646
- By:
- Publication type:
- Article
Interleukin-22, a T<sub>H</sub>17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1.
- Published in:
- Nature Immunology, 2013, v. 14, n. 12, p. 1229, doi. 10.1038/ni.2743
- By:
- Publication type:
- Article
Targeting LGR5<sup>+</sup> cells with an antibody-drug conjugate for the treatment of colon cancer.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 314, p. 1, doi. 10.1126/scitranslmed.aac7433
- By:
- Publication type:
- Article
B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity.
- Published in:
- Annals of Neurology, 2010, v. 68, n. 3, p. 369, doi. 10.1002/ana.22081
- By:
- Publication type:
- Article
The kinase IRAK4 promotes endosomal TLR and immune complex signaling in B cells and plasmacytoid dendritic cells.
- Published in:
- Science Signaling, 2020, v. 13, n. 634, p. 1, doi. 10.1126/scisignal.aaz1053
- By:
- Publication type:
- Article
MAP4K4 regulates integrin-FERM binding to control endothelial cell motility.
- Published in:
- Nature, 2015, v. 519, n. 7544, p. 425, doi. 10.1038/nature14323
- By:
- Publication type:
- Article
Correction: Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis.
- Published in:
- PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0190158
- By:
- Publication type:
- Article
Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors.
- Published in:
- PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0185862
- By:
- Publication type:
- Article